The Emerging Role Of Radioimmunotherapy In Haematological Malignancies
Open Access
- 29 March 2000
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 108 (4) , 679-688
- https://doi.org/10.1046/j.1365-2141.2000.01926.x
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Antibodies Stage a Comeback in Cancer TreatmentScience, 1998
- Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using131I-LYM-1 AntibodyCancer Biotherapy & Radiopharmaceuticals, 1998
- Radioimmunotherapy of Lymphoma: A UC Davis ExperienceHybridoma, 1995
- Human Immune Respone to Monoclonal AntibodiesJournal of Immunotherapy, 1994
- Radiolabeled-Antibody Therapy of B-Cell Lymphoma with Autologous Bone Marrow SupportNew England Journal of Medicine, 1993
- Radioimmunotherapy of B-Cell Lymphoma with [131I]Anti-B1 (Anti-CD20) AntibodyNew England Journal of Medicine, 1993
- Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.Proceedings of the National Academy of Sciences, 1989
- A phase 1a clinical trial of LYM‐1 monoclonal antibody serotherapy in patients with refractory b cell malignanciesHematological Oncology, 1989
- Long-term results of low dose total body irradiation for advanced non-hodgkin lymphomaInternational Journal of Radiation Oncology*Biology*Physics, 1987
- The sensitivity of lymphocytes to ionising radiationThe Journal of Pathology and Bacteriology, 1952